Colorado NGO Behind CBD for Pediatric Epilepsy Shifts Attention to Psychedelics Via Sister Organization

Last year, the Stanley Brothers signed a partnership between a professional sports league and a hemp/marijuana brand, becoming the first to do so. Prior to this, the company’s CBD products, including Charlotte’s Web, had been gaining popularity in Colorado, especially after a surge in their use by children with epileptic seizures.

Paige Figi, mother to the late Charlotte, who experienced seizures on a daily basis, was the first to discover this benefit. Together with Heather Jackson, whose son also used Charlotte’s Web, Figi founded Realm of Caring to conduct more studies into CBD in 2013.

Many years later, medical cannabis is legal in 38 states, partly because of the significant roles the “cannabis moms” who are  affiliated with Realm of Caring played when campaigning for legalization. The group successfully helped change cannabis laws in Utah, Texas, Alabama, Wyoming, Florida, Wisconsin, Tennessee, Georgia, Virginia, Iowa, South Carolina, Kentucky, Oklahoma, Maryland, North Carolina, Minnesota, New York, Missouri and Mississippi. This is in addition to improving the quality of life of many families, educating parents and studying the impact of cannabis with the School of Medicine and Johns Hopkins University.

Now, Realm of Caring’s sister organization plans to conduct research on psychedelics. The organization in question, Unlimited Sciences, will investigate the medical benefits of psilocybin, which is found in magic mushrooms. Psilocybin is an active compound with hallucinogenic properties that changes an individual’s sense of time, causes mental and visual hallucinations, and alters perception when ingested.

Thus far, a longitudinal study carried out by Realms of Caring on psilocybin has found that the psychedelic’s broad therapeutic potential produced lasting improvements in symptoms of mental health, which included reductions in depression and anxiety. It should be noted that some side effect were observed in a few patients, including mood fluctuations, a need for medical care and a need for psychiatric care.

Unlimited Sciences is set to continue with this research after it received authorization to carry out studies. The Institutional Review Boards under the FDA issued this authorization.

Matthew X. Lowe, chief scientific officer and executive director at Unlimited Sciences, stated that psychedelics have been used in religious ceremonies for millennia and that the drugs are the next frontier for mental health treatment. He added that the company is committed to bringing evidence-based awareness and education to the public.

Individuals are cautioned against self-administration of psychedelics, especially if you or your family has a history of mental health conditions such as

Unlimited Sciences joins a growing list of companies, such as atai Life Sciences N.V. (NASDAQ: ATAI), that are seeking to commercialize therapeutic formulations from psychedelic compounds.

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published:

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
415.949.5050 Office

PsychedelicNewsWire is part of the InvestorBrandNetwork.


Select A Month

PsychedelicNewsWire Currently Accepts



Bitcoin Cash

Bitcoin Cash

Doge Coin






USD Coin

USD Coin

Contact us: 415.949.5050